Desensitisation to liposomal amphotericin B

被引：11
|
作者：
Shadur, Bella [1 ,2 ]
Trahair, Toby Nicholas [2 ,3 ,4 ]
O'Brien, Tracey [2 ,3 ]
Russell, Susan Jane [2 ,3 ]
Ziegler, John Bernard [1 ,2 ]
机构：
[1] Sydney Childrens Hosp, Dept Immunol & Infect Dis, High St, Sydney, NSW 2031, Australia
[2] Univ New South Wales, Fac Med, Sch Womens & Childrens Hlth, Sydney, NSW, Australia
[3] Sydney Childrens Hosp, Kids Canc Ctr, Sydney, NSW, Australia
[4] Lowy Canc Res Ctr, Childrens Canc Inst, Sydney, NSW, Australia
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE | 2017年 / 5卷 / 01期
关键词：
SAFETY;
D O I：
10.1016/j.jaip.2016.08.006
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：181 / 183
页数：3
相关论文
共 50 条
  • [1] Liposomal amphotericin B-the past
    Bruggemann, R. J.
    Jensen, G. M.
    Lass-Florl, C.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 : 3 - 10
  • [2] Pharmacodynamics of Amphotericin B Deoxycholate, Amphotericin B Lipid Complex, and Liposomal Amphotericin B against Aspergillus fumigatus
    Al-Nakeeb, Zaid
    Petraitis, Vidmantas
    Goodwin, Joanne
    Petraitiene, Ruta
    Walsh, Thomas J.
    Hope, William W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (05) : 2735 - 2745
  • [3] Comparison between liposomal formulations of amphotericin B
    Adler-Moore, Jill P.
    Gangneux, Jean-Pierre
    Pappas, Peter G.
    MEDICAL MYCOLOGY, 2016, 54 (03) : 223 - 231
  • [4] Liposomal amphotericin B to treat visceral leishmaniasis
    Monge-Maillo, Begona
    Lopez-Velez, Rogelio
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2021, 38 (02): : 101 - 104
  • [5] Liposomal amphotericin B as a treatment for human leishmaniasis
    Balasegaram, Manica
    Ritmeijer, Koert
    Lima, Maria Angeles
    Burza, Sakib
    Genovese, Gemma Ortiz
    Milani, Barbara
    Gaspani, Sara
    Potet, Julien
    Chappuis, Francois
    EXPERT OPINION ON EMERGING DRUGS, 2012, 17 (04) : 493 - 510
  • [6] Clinical experience on the use of liposomal amphotericin B in the ICU
    Ramos, Silvia
    Solchaga-Sanchez, Isabel
    Calvo, Alberto
    Power, Mercedes
    Garcia-Ramos, Sergio
    Pineiro, Patricia
    MEDICINA INTENSIVA, 2025, 49 (01) : 50 - 53
  • [7] Liposomal amphotericin B: Clinical pharmacology, pharmacokinetics and pharmacodynamics
    Azanza Perea, Jose Ramon
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2021, 38 (02): : 52 - 55
  • [8] Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex
    Wade, Rolin L.
    Chaudhari, Paresh
    Natoli, Jaime L.
    Taylor, Robert J.
    Nathanson, Brian H.
    Horn, David L.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2013, 76 (03) : 361 - 367
  • [9] Experience with Liposomal Amphotericin B in Outpatient Parenteral Antimicrobial Therapy
    Burnett, Yvonne
    Spec, Andrej
    Ahmed, Mohamed M.
    Powderly, William G.
    Hamad, Yasir
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (06)
  • [10] Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals
    Wasmann, Roeland E.
    Smit, Cornelis
    van Dongen, Eric P. H.
    Wiezer, Rene M. J.
    Adler-Moore, Jill
    de Beer, Yvo M.
    Burger, David M.
    Knibbe, Catherijne A. J.
    Bruggemann, Roger J. M.
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (10) : 2213 - 2215
12345